Skip to main content

Abstract

Delayed cerebral vasospasm occurring between the 4th day and the 14th day after subarachnoid hemorrhage (SAH) affects the patient outcome seriously. Its occurrence correlates to the presence and the amount of subarachnoid clot. It is different from ordinary constriction of vessel, since the cerebral vasospasm is delayed onset and long lasting contraction of the vessel which also involves histological changes. Although almost all substances which existed in blood clot had been investigated as candidates caused delayed vasospasm, no substance by itself had been accepted as a cause. Watanabe et al.1 and Shimizu et al.2 reported that 12-hydroxyeicosatetraenoic acid (12-HETE) was detected in subarachnoid clot using the canine SAH model, and 5–1 ipoxygenase pathway of arterial wall with vasospasm was much activated compared with the control vessel. Moreover, 12-hydroperoxyeicosatetraenoic acid (12-HPETE) injected into canine major cistern was produced delayed onset and long lasting vasospasm comparable to the canine SAH model. The injected 12-HPETE into the canine major cistern was decreased rapidly and disappeared from cerebrospinal fluid (CSF) at 6 hours after its injection3. It was interesting and curious that the vasospasm occurred after 12-HPETE disappeared from CSF. The present study was aimed to clarify the trace of injected 12-HPETE into canine major cistern.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T. Watanabe, T. Asano. T. Shimizu, Y. Seyama, and K. Takakura, Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm, J. Neurochem. 50:1145 (1988).

    Article  PubMed  CAS  Google Scholar 

  2. T. Shimizu, T. Watanabe, T. Asano, Y. Seyama, and K. Takakura, Activation of the arachidonate 5-lipoxy-genase pathway in the canine basilar artery after experimental subarachnoid hemorrhage, J. Neurochem. 51:1126 (1988).

    Article  PubMed  CAS  Google Scholar 

  3. T. Watanabe, T. Asano, and T. Shimizu, Arachidonic acid lipoxygenase products participate in the pathogenesis of delayed cerebral vasospasm, Adv. Neurochem. 7:139 (1992).

    CAS  Google Scholar 

  4. T. Watanabe, T. Sasaki, T. Asano, K. Takakura, K. Sano, T. Fuchinoue, K. Watanabe, S. Yoshimura, and K. Abe, Changes in glutathione peroxidase and lipid peroxides in cerebrospinal fluid and serum after subarachnoid hemorrhage—with special reference to the occurrence of cerebral vasospasm, Neuro. Med. Chir. 28:645 (1988)

    Article  CAS  Google Scholar 

  5. L. Wang, T. L. Kaduce, and A. A. Spector, Localization of 12-hydroxyeicosatetraenoic acid in endothelial cells, J. Lipid Res. 31:2265 (1990)

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Okamoto, H. et al. (1997). Role of 12-HPETE in the Pathogenesis of Cerebral Vasospasm. In: Honn, K.V., Marnett, L.J., Nigam, S., Jones, R.L., Wong, P.YK. (eds) Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3. Advances in Experimental Medicine and Biology, vol 407. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1813-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1813-0_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1815-4

  • Online ISBN: 978-1-4899-1813-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics